Lack of correlation between different congestion markers in acute decompensated heart failure.
Acute decompensated heart failure
Congestion
Dyspnea
Inferior vena cava
NT-proBNP
Journal
Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
09
01
2022
accepted:
03
05
2022
pubmed:
2
6
2022
medline:
21
1
2023
entrez:
1
6
2022
Statut:
ppublish
Résumé
Hospitalizations for acute decompensated heart failure (ADHF) are commonly associated with congestion-related signs and symptoms. Objective and quantitative markers of congestion have been identified, but there is limited knowledge regarding the correlation between these markers. Patients hospitalized for ADHF irrespective of left ventricular ejection fraction were included in a prospective registry. Assessment of congestion markers (e.g., NT-proBNP, maximum inferior vena cava diameter, dyspnea using visual analogue scale, and a clinical congestion score) was performed systematically on admission and at discharge. Telephone interviews were performed to assess clinical events, i.e., all-cause death or readmission for cardiovascular cause, after discharge. Missing values were handled by multiple imputation. In total, 130 patients were prospectively enrolled. Median length of hospitalization was 9 days (interquartile range 6 to 16). All congestion markers declined from admission to discharge (p < 0.001). No correlation between the congestion markers could be identified, neither on admission nor at discharge. The composite endpoint of all-cause death or readmission for cardiovascular cause occurred in 46.2% of patients. Only NT-proBNP at discharge was predictive for this outcome (hazard ratio 1.48, 95% confidence interval 1.15 to 1.90, p = 0.002). No correlation between quantitative congestion markers was observed. Only NT-proBNP at discharge was significantly associated with the composite endpoint of all-cause death or readmission for cardiovascular cause. Findings indicate that the studied congestion markers reflect different aspects of congestion.
Sections du résumé
BACKGROUND
BACKGROUND
Hospitalizations for acute decompensated heart failure (ADHF) are commonly associated with congestion-related signs and symptoms. Objective and quantitative markers of congestion have been identified, but there is limited knowledge regarding the correlation between these markers.
METHODS
METHODS
Patients hospitalized for ADHF irrespective of left ventricular ejection fraction were included in a prospective registry. Assessment of congestion markers (e.g., NT-proBNP, maximum inferior vena cava diameter, dyspnea using visual analogue scale, and a clinical congestion score) was performed systematically on admission and at discharge. Telephone interviews were performed to assess clinical events, i.e., all-cause death or readmission for cardiovascular cause, after discharge. Missing values were handled by multiple imputation.
RESULTS
RESULTS
In total, 130 patients were prospectively enrolled. Median length of hospitalization was 9 days (interquartile range 6 to 16). All congestion markers declined from admission to discharge (p < 0.001). No correlation between the congestion markers could be identified, neither on admission nor at discharge. The composite endpoint of all-cause death or readmission for cardiovascular cause occurred in 46.2% of patients. Only NT-proBNP at discharge was predictive for this outcome (hazard ratio 1.48, 95% confidence interval 1.15 to 1.90, p = 0.002).
CONCLUSION
CONCLUSIONS
No correlation between quantitative congestion markers was observed. Only NT-proBNP at discharge was significantly associated with the composite endpoint of all-cause death or readmission for cardiovascular cause. Findings indicate that the studied congestion markers reflect different aspects of congestion.
Identifiants
pubmed: 35648271
doi: 10.1007/s00392-022-02036-9
pii: 10.1007/s00392-022-02036-9
pmc: PMC9849150
doi:
Substances chimiques
Natriuretic Peptide, Brain
114471-18-0
Peptide Fragments
0
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
75-86Informations de copyright
© 2022. The Author(s).
Références
J Am Soc Echocardiogr. 2015 Dec;28(12):1420-7
pubmed: 26272698
JAMA. 2005 Oct 5;294(13):1625-33
pubmed: 16204662
Intensive Care Med. 2016 Jul;42(7):1164-7
pubmed: 27107754
Eur J Heart Fail. 2019 Feb;21(2):137-155
pubmed: 30600580
Acad Emerg Med. 2011 Jan;18(1):98-101
pubmed: 21414063
Emerg Med J. 2014 May;31(5):369-73
pubmed: 23428721
Eur J Heart Fail. 2019 Jul;21(7):904-916
pubmed: 30666769
Circulation. 2018 Apr 17;137(16):1671-1683
pubmed: 29242350
Heart Vessels. 2017 Jul;32(7):856-864
pubmed: 28116486
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
Eur Heart J. 2013 Mar;34(11):835-43
pubmed: 23293303
Int J Cardiovasc Imaging. 2014 Oct;30(7):1289-95
pubmed: 24939288
JACC Heart Fail. 2018 Apr;6(4):273-285
pubmed: 29226815
JAMA. 1989 Feb 10;261(6):884-8
pubmed: 2913385
Eur J Heart Fail. 2017 Jun;19(6):739-747
pubmed: 28296139
JACC Cardiovasc Imaging. 2013 Jan;6(1):16-28
pubmed: 23328557
Eur J Heart Fail. 2008 Sep;10(9):824-39
pubmed: 18760965
Eur J Heart Fail. 2010 May;12(5):423-33
pubmed: 20354029
J Am Soc Echocardiogr. 2013 Sep;26(9):1033-42
pubmed: 23860098
Eur J Echocardiogr. 2011 Sep;12(9):665-70
pubmed: 21810825
JACC Cardiovasc Imaging. 2008 Sep;1(5):595-601
pubmed: 19356487
Eur J Heart Fail. 2003 Dec;5(6):767-74
pubmed: 14675855
Heart. 2014 Jan;100(2):115-25
pubmed: 24179162
ESC Heart Fail. 2020 Jun;7(3):973-983
pubmed: 31991063
Eur J Heart Fail. 2017 Jul;19(7):883-892
pubmed: 28387033
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
Dtsch Arztebl Int. 2009 Apr;106(16):269-75
pubmed: 19547628
Eur J Heart Fail. 2010 Oct;12(10):1130-9
pubmed: 20732868
Circ Heart Fail. 2008 Sep;1(3):170-7
pubmed: 19675681
Eur J Cardiovasc Nurs. 2015 Aug;14(4):286-93
pubmed: 25122616
Eur J Heart Fail. 2021 May;23(5):703-712
pubmed: 33118672
Int J Cardiol. 2019 Jun 15;285:40-46
pubmed: 30905515
Eur J Heart Fail. 2013 Apr;15(4):456-64
pubmed: 23159547
Am J Cardiol. 2019 Aug 1;124(3):402-408
pubmed: 31128735
Eur Heart J. 2021 Jun 21;42(24):2331-2343
pubmed: 33791787
Circulation. 2007 Sep 25;116(13):1482-7
pubmed: 17724259
Am J Emerg Med. 2015 Nov;33(11):1602-5
pubmed: 26306433
Heart Fail Rev. 2014 Aug;19(4):453-70
pubmed: 25062653
Lancet. 2011 Feb 19;377(9766):658-66
pubmed: 21315441
Am Heart J. 2000 Dec;140(6):840-7
pubmed: 11099986
Nat Rev Cardiol. 2020 Oct;17(10):641-655
pubmed: 32415147
Circ Heart Fail. 2016 Aug;9(8):e002922
pubmed: 27436837
Crit Care. 2014 Jan 14;18(1):R14
pubmed: 24423180
J Biol Eng. 2018 Jan 12;12:2
pubmed: 29344085
Am J Cardiol. 2009 Jan 15;103(2):246-7
pubmed: 19121445
J Card Fail. 2008 Nov;14(9):777-84
pubmed: 18995183